Venous Disease

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Merit Medical
Merit MedicalSOUTH JORDAN, UT
1 program
Central Venous AccessN/A1 trial
Active Trials
NCT05050799Recruiting30Est. Dec 2026

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Merit MedicalCentral Venous Access

Clinical Trials (1)

Total enrollment: 30 patients across 1 trials

NCT05050799Merit MedicalCentral Venous Access

US Post-Market Surveillance Study of the Surfacer System

Start: Feb 2022Est. completion: Dec 202630 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 30 patients
1 companies competing in this space